More articles from Accelerated Communication

You have access
Endoxifen, the Active Metabolite of Tamoxifen, Is a Substrate of the Efflux Transporter P-Glycoprotein (Multidrug Resistance 1)
Wendy A. Teft, Sara E. Mansell and Richard B. Kim

Drug Metabolism and Disposition March 2011, 39 (3) 558-562; DOI: https://doi.org/10.1124/dmd.110.036160
You have access
Assessment of a Micropatterned Hepatocyte Coculture System to Generate Major Human Excretory and Circulating Drug Metabolites
Wendy WeiWei Wang, Salman R. Khetani, Stacy Krzyzewski, David B. Duignan and R. Scott Obach

Drug Metabolism and Disposition October 2010, 38 (10) 1900-1905; DOI: https://doi.org/10.1124/dmd.110.034876
You have access
MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting
Yu-Zhuo Pan, Wenqing Gao and Ai-Ming Yu

Drug Metabolism and Disposition October 2009, 37 (10) 2112-2117; DOI: https://doi.org/10.1124/dmd.109.027680
You have access
Metabolic Activation of Nevirapine in Human Liver Microsomes: Dehydrogenation and Inactivation of Cytochrome P450 3A4
Bo Wen, Yuan Chen and William L. Fitch

Drug Metabolism and Disposition July 2009, 37 (7) 1557-1562; DOI: https://doi.org/10.1124/dmd.108.024851
You have access
INTESTINAL PERFUSION WITH MESENTERIC BLOOD SAMPLING IN WILD-TYPE AND KNOCKOUT MICE
Raf Mols, Joachim Brouwers, Alfred H. Schinkel, Pieter Annaert and Patrick Augustijns

Drug Metabolism and Disposition June 2009, 37 (6) 1334-1337; DOI: https://doi.org/10.1124/dmd.109.026591
You have access
An Unexpected Synergist Role of P-Glycoprotein and Breast Cancer Resistance Protein on the Central Nervous System Penetration of the Tyrosine Kinase Inhibitor Lapatinib (N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016)
Joseph W. Polli, Katie L. Olson, John P. Chism, Lisa St. John-Williams, Russell L. Yeager, Sesha M. Woodard, Vicky Otto, Stephen Castellino and Victoria E. Demby

Drug Metabolism and Disposition February 2009, 37 (2) 439-442; DOI: https://doi.org/10.1124/dmd.108.024646
You have access
PREDICTION OF DRUG-DRUG INTERACTIONS FROM IN VITRO INDUCTION DATA
Odette A. Fahmi, Sherri Boldt, Mary Kish, R. Scott Obach and Larry M. Tremaine

Drug Metabolism and Disposition September 2008, 36 (9) 1971-1974; DOI: https://doi.org/10.1124/dmd.108.021907
You have access
In Vitro Metabolic Activation of Lumiracoxib in Rat and Human Liver Preparations
Ying Li, J. Greg Slatter, Zhoupeng Zhang, Yan Li, George A. Doss, Matthew P. Braun, Ralph A. Stearns, Dennis C. Dean, Thomas A. Baillie and Wei Tang

Drug Metabolism and Disposition February 2008, 36 (2) 469-473; DOI: https://doi.org/10.1124/dmd.107.019018
You have access
Mode of Administration-Dependent Brain Uptake of Indomethacin: Sustained Systemic Input Increases Brain Influx
Arik Dahan and Amnon Hoffman

Drug Metabolism and Disposition February 2007, 35 (2) 321-324; DOI: https://doi.org/10.1124/dmd.106.011817
You have access
GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS
Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson

Drug Metabolism and Disposition January 2006, 34 (1) 191-197; DOI: https://doi.org/10.1124/dmd.105.007633

Main menu

User menu

Search

More articles from Accelerated Communication

Pages

Navigate

More Information

ASPET's Other Journals